TAXIS Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TAXIS Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10871
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TAXIS Pharmaceuticals Inc (TAXIS Pharma) is a biopharmaceutical company that treats, reduce and eliminates the threat of current and emergent antimicrobial resistance across a range of infectious diseases. It research new classes of antibiotic agents to treat life-threatening and multidrug-resistant bacterial infections. TAXIS Pharma’s pipeline includes various investigational antibiotics with novel mechanisms of action including efflux pump inhibition (EPI), inhibition of the bacterial protein FtsZ, and modulation of another bacterial protein (MreB). The company offers services such as research and development, chemical synthesis and laboratory services. Its products are used in treatment of bacterial infections, and others. TAXIS Pharma is headquartered in Monmouth Junction, New Jersey, the US.

TAXIS Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
TAXIS Pharma Acquires Antimicrobial Drugs from Biota Pharma 10
Venture Financing 11
Taxis Pharma to Raise USD5 Million in Venture Financing 11
Taxis Pharma Raises USD1.2 Million in Venture Financing 12
Taxis Pharma Raises USD3 Million in Venture Financing 13
TAXIS Pharmaceuticals Inc – Key Competitors 14
TAXIS Pharmaceuticals Inc – Key Employees 15
TAXIS Pharmaceuticals Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAXIS Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TAXIS Pharma Acquires Antimicrobial Drugs from Biota Pharma 10
Taxis Pharma to Raise USD5 Million in Venture Financing 11
Taxis Pharma Raises USD1.2 Million in Venture Financing 12
Taxis Pharma Raises USD3 Million in Venture Financing 13
TAXIS Pharmaceuticals Inc, Key Competitors 14
TAXIS Pharmaceuticals Inc, Key Employees 15

List of Figures
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[TAXIS Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evergreen Packaging Inc:企業の戦略・SWOT・財務情報
    Evergreen Packaging Inc - Strategy, SWOT and Corporate Finance Report Summary Evergreen Packaging Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • HalcyGen Pharmaceuticals Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HalcyGen Pharmaceuticals Limite …
  • Accu-Break Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, …
  • Mintails Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mintails Limited Mergers and Ac …
  • DTEK Energy B.V.:電力:M&Aディール及び事業提携情報
    Summary DTEK Energy B.V. (DTEK Energy), formerly DTEK Holdings B.V., is a vertically-integrated utility that conducts coal mining and processing; electricity generation; manufacture of mining machinery; trading of coal and electricity in Ukrainian and international markets; and repair and maintenanc …
  • Intermountain Healthcare Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • Dialogic, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dialogic, Inc. Mergers and Acqu …
  • Cal-Comp Electronics (Thailand) Public Company Limited (CCET):企業の財務及び戦略的SWOT分析
    Summary Cal-Comp Electronics (Thailand) Public Company Limited (Cal-Comp) is an electronic equipment company that provides manufacturing and customization solutions. The company offers services such as electronics manufacturing services (EMS), original design manufacturing (ODM), original equipment …
  • R Systems International Limited (RSYSTEMS):企業の財務及び戦略的SWOT分析
    Summary R Systems International Limited (R Systems) is a software solution provider that provides information technology solutions and business process outsourcing services. The company offers services such as iPLM services, testing services, application services, packaged services, and BPO and KPO …
  • Cellectar Biosciences Inc (CLRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectar Biosciences Inc (Cellectar) develops phospholipid drug conjugates (PDCs) for the treatment and diagnosis of cancer. Its lead product, CLR 131, is a small-molecule radiotherapeutic PDC, being developed for the treatment of relapse or refractory multiple myeloma. Cellectar’s other pr …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Campus Management Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Campus Management Corp. Mergers …
  • Asseco Poland SA (ACP):企業の財務及び戦略的SWOT分析
    Summary Asseco Poland SA (Asseco Poland) is an information technology company that develops software solutions. The company offers products in categories such as finance, competence center, infrastructure, public institutions, and telco and utilities. Its information technology infrastructure soluti …
  • PharmAthene, Inc.:企業のM&A・提携・投資分析
    PharmAthene, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PharmAthene, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • PPG Industries, Inc. (PPG):企業のM&A・提携動向(エネルギー分野)
    Summary PPG Industries, Inc. (PPG) is a chemical manufacturing company. It manufactures and markets coatings, paints, optical and specialty products. The company provides protective and decorative coatings and finishes to customers in construction, consumer products, industrial and transportation an …
  • The State Trading Corporation of India Limited (STCINDIA):企業財務及び戦略的SWOT分析
    Summary The State Trading Corporation of India Limited (STC) is an international trading company that provides agro commodities, hydrocarbons, metals, minerals, ores, fertilizers and petrochemicals. The company’s agro commodities include grains, pulses, edible oil, oil seeds and extractions, coarse …
  • Itochu Corp (8001):石油・ガス:M&Aディール及び事業提携情報
    Summary Itochu Corp (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, insurance …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Olympus Corp (7733):医療機器:M&Aディール及び事業提携情報
    Summary Olympus Corporation (Olympus) provides precision machinery and instruments. It develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers medical systems such as endotherapy devices, medical endoscopes and t …
  • E. I. du Pont de Nemours and Company (DD):企業のM&A・提携動向(石油・ガス分野)
    Summary E. I. du Pont de Nemours and Company (DuPont) is a science and technology company. It provides science-based solutions in the fields of health care and medical, food and nutrition, construction, safety and security, electronics, transportation, and others. The company's products include inse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆